SΔC-Fer

A candidate COVID-19 protein subunit vaccine.

Phase of research

Potential treatment - pre-clinical evidence

How it helps

Vaccine

Drug status

Experimental

1
Supporting references
0
Contradictory references
0
AI-suggested references
0
Clinical trials

General information

SΔC-Fer is an experimental COVID-19 vaccine. It is based on SARS-CoV-2 Spike protein lacking the 70 amino-acid C-terminal fragment. The protein is multivalently displayed on Helicobacter pylori ferritin nanoparticles (Powell et al., 2021).

 


Supporting references

Link Tested on Impact factor Notes Publication date
A Single Immunization with Spike-Functionalized Ferritin Vaccines Elicits Neutralizing Antibody Responses against SARS-CoV-2 in Mice
Biophysical assay Protein factor Animal model In vitro Mixed substance
in vitro binding assay; in vitro biophysical assay; cryo-EM; BALB/c mice 12.69

The vaccine particles were properly folded and elicited a neutralizing antibody response in mice after a single immunization. The response was at least 2-fold stronger than the one in convalescent patient sera. A boosting dose further increased the antibody titres.

Jan/05/2021